Henley Health Economics Limited Email Formats

About Henley Health Economics Limited

Executive leadership with broad strategic and operational knowledge and ‘know-how’ in global market access, HE&OR, and development-commercial strategy. Demonstrated success in leading high-performing international teams to deliver business-critical projects: * Successfully generating over 200 health technology assessment (HTA) submissions and pricing and reimbursement (P&R) negotiations, undertaken by +30 international government agencies, that facilitated the launch of 19 products/new indications (16 in EU and 14 in the USA). * Leading Phase I-IV international studies, registration programmes and registries. * Establishing de novo functions/departments within organisations with an emergent requirement for commercial and competitive strategy, health economics and outcomes research (HE&OR), and market access teams. * Strategically evaluating early- and late-stage products, corporate portfolios, and full drug development processes - to efficiently optimise the value of assets to the company, regulator, healthcare system decision-makers and patients. * Supporting business development in-/out licensing activities and commercial partnerships. * In-depth clinical and published (+50, www.researchgate.net) scientific experience of multiple therapeutic areas including: Immuno-oncology | inflammatory Immunology | ultra-rare / orphan diseases | respiratory | stroke | anti-infectives | cardiovascular | obesity | renal | virology | neurology | emergency and critical care medicine.

View contact profiles from Henley Health Economics Limited